These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17356927)

  • 1. Survival of patients discharged after acute myocardial infarction and evidence-based drug therapy.
    Gouya G; Reichardt B; Ohrenberger G; Wolzt M
    Eur J Epidemiol; 2007; 22(3):145-9. PubMed ID: 17356927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital variation in use of secondary preventive medicine after discharge for first acute myocardial infarction during 1995-2004.
    Rasmussen S; Abildstrom SZ; Rasmussen JN; Gislason GH; Schramm TK; Folke F; Køber L; Torp-Pedersen C; Madsen M
    Med Care; 2008 Jan; 46(1):70-7. PubMed ID: 18162858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.
    Filippi A; D'Ambrosio G; Giustini SE; Pecchioli S; Mazzaglia G; Cricelli C
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):714-8. PubMed ID: 19465867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of renin-angiotensin system inhibitors on long-term survival in patients treated with beta blockers and antiplatelet agents after acute myocardial infarction (from the MONICA/KORA Myocardial Infarction Registry).
    Amann U; Kirchberger I; Heier M; Zirngibl A; von Scheidt W; Kuch B; Peters A; Meisinger C
    Am J Cardiol; 2014 Aug; 114(3):329-35. PubMed ID: 24927969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
    Lee HY; Cooke CE; Robertson TA
    J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value.
    Lee JH; Yang DH; Park HS; Cho Y; Jeong MH; Kim YJ; Kim KS; Hur SH; Seong IW; Hong TJ; Cho MC; Kim CJ; Jun JE; Park WH; Chae SC;
    Am Heart J; 2010 Jun; 159(6):1012-9. PubMed ID: 20569714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age and sex inequalities in the prescription of evidence-based pharmacological therapy following an acute coronary syndrome in Portugal: the EURHOBOP study.
    Pereira M; Araújo C; Dias P; Lunet N; Subirana I; Marrugat J; Capewell S; Bennett K; Azevedo A
    Eur J Prev Cardiol; 2014 Nov; 21(11):1401-8. PubMed ID: 23787795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Polyunsaturated Fatty Acid Treatment on Postdischarge Outcomes After Acute Myocardial Infarction.
    Greene SJ; Temporelli PL; Campia U; Vaduganathan M; Degli Esposti L; Buda S; Veronesi C; Butler J; Nodari S
    Am J Cardiol; 2016 Feb; 117(3):340-6. PubMed ID: 26708689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction.
    Shore S; Jones PG; Maddox TM; Bradley SM; Stolker JM; Arnold SV; Parashar S; Peterson P; Bhatt DL; Spertus J; Ho PM
    Heart; 2015 May; 101(10):800-7. PubMed ID: 25801001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Patient Enrollment in Medicare Part D With Outcomes After Acute Myocardial Infarction.
    Goyal A; de Lemos JA; Peng SA; Thomas L; Amsterdam EA; Hockenberry JM; Peterson ED; Wang TY
    Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):567-75. PubMed ID: 26508667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discharge prescriptions following admission for acute myocardial infarction at tertiary care and community hospitals in Quebec.
    Beck CA; Lauzon C; Eisenberg MJ; Huynh T; Dion D; Roux R; Racine N; Carignan S; Diodati JG; Charbonneau F; Lévesque C; Pouliot J J; Pilote L L
    Can J Cardiol; 2001 Jan; 17(1):33-40. PubMed ID: 11173312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No gender differences in prognosis and preventive treatment in patients with AMI without significant stenoses.
    Hansen KW; Hvelplund A; Abildstrøm SZ; Prescott E; Madsen M; Madsen JK; Jensen JS; Thuesen L; Thayssen P; Tilsted HH; Jørgensen E; Galatius S
    Eur J Prev Cardiol; 2012 Aug; 19(4):746-54. PubMed ID: 21724682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Socio-demographic differences in adherence to evidence-based drug therapy after hospital discharge from acute myocardial infarction: a population-based cohort study in Rome, Italy.
    Kirchmayer U; Agabiti N; Belleudi V; Davoli M; Fusco D; Stafoggia M; Arcà M; Barone AP; Perucci CA
    J Clin Pharm Ther; 2012 Feb; 37(1):37-44. PubMed ID: 21294760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex Disparities in Post-Acute Myocardial Infarction Pharmacologic Treatment Initiation and Adherence: Problem for Young Women.
    Smolina K; Ball L; Humphries KH; Khan N; Morgan SG
    Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):586-92. PubMed ID: 26462876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis.
    Setoguchi S; Glynn RJ; Avorn J; Mittleman MA; Levin R; Winkelmayer WC
    J Am Coll Cardiol; 2008 Apr; 51(13):1247-54. PubMed ID: 18371553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of long-term adherence to evidence-based combination drug therapy after acute myocardial infarction with all-cause mortality. A prospective cohort study based on claims data.
    Kuepper-Nybelen J; Hellmich M; Abbas S; Ihle P; Griebenow R; Schubert I
    Eur J Clin Pharmacol; 2012 Oct; 68(10):1451-60. PubMed ID: 22476389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tackling inequalities: are secondary prevention therapies for reducing post-infarction mortality used without disparities?
    Buja A; Boemo DG; Furlan P; Bertoncello C; Casale P; Baldovin T; Marcolongo A; Baldo V
    Eur J Prev Cardiol; 2014 Feb; 21(2):222-30. PubMed ID: 22997352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor short-term survival and low use of cardiovascular medications in elderly dialysis patients after acute myocardial infarction.
    Winkelmayer WC; Charytan DM; Levin R; Avorn J
    Am J Kidney Dis; 2006 Feb; 47(2):301-8. PubMed ID: 16431259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Organisational determinants of adherence to secondary prevention medications after acute myocardial infarction].
    Perrone E; Lenzi J; Avaldi VM; Castaldini I; Protonotari A; Rucci P; Piccinni C; Morini M; Fantini MP
    Epidemiol Prev; 2015; 39(2):106-14. PubMed ID: 26036739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parabolas of medication use and discontinuation after myocardial infarction--are we closing the treatment gap?
    Hudson M; Richard H; Pilote L
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):773-85. PubMed ID: 17486661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.